Read more
2:44 PM · 31 October 2022

Top US stock reports to watch this week (31.10.2022)

Reports from US mega-tech companies were key points in last week's earnings calendar and disappointing results presented by those companies exerted pressure on their shares and tech indices, like Nasdaq-100 (US100). This week will not see releases of reports from any mega-cap stocks but is packed with reports from a number of top-tier companies from various industries. Table below presents key releases scheduled for the next four days. Thursday looks to be the most intense but key reports will be released on each day of the week. Nevertheless, traders should keep in mind that main drivers for stock markets this week will likely be rate decision from Fed (Wednesday, 6:00 pm GMT) and Bank of England (Thursday, 12:00 pm GMT) as well as the US NFP report for October (Friday, 12:30 pm GMT).

Top US stock reports to watch this week. Source: Bloomberg, XTB Research

7 May 2026, 9:46 PM

Daily Summary: A shift in sentiment at the end of the day 💥⬇️

7 May 2026, 5:50 PM

Stock of the Week AMD: From second choice to core pillar of the AI infrastructure

7 May 2026, 5:46 PM

US OPEN: Wall Street opens higher 🔼 Datadog and ARM in the spotlight 💥

7 May 2026, 3:51 PM

Rheinmetall earninigs: Weak sales overshadow strong prospects

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.